Clinical Trials in Fuencarral-El Pardo, Madrid
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
CRF2 Agonist for the Treatment of Worsening Heart Failure
Worsening Heart Failure
Corteria Pharmaceuticals300 enrolled55 locationsNCT06815471
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic Awareness and Shared Decision Making.
CancerDepressionAnxiety
Fundación Sociedad Española de Oncologia Médica540 enrolled18 locationsNCT07168096